Advanced Oncotherapy Live Discussion

Live Discuss Polls Ratings
Page

nk1999 26 Jan 2015

Westhouse "Westhouse Securities reiterated its "buy" rating and 9p target price on Advanced Oncotherapy (AVO) after the company announced it had successfully manufactured the first coupled cavity linac modules, a key part in its LIGHT proton therapy system. The broker said that the investment case for Advanced Oncotherapy depends on it being able to come to market on schedule and that this represents a significant milestone in the process. The shares grew by 0.05p to 3.9p."From UK-Analyst.

nk1999 20 Jan 2015

Westhouse From UK-Amalyst:"Westhouse Resources reiterated its "buy" rating on Advanced Oncotherapy (AVO) and repeated the opinion that it is a top pick for 2015 after CERN set up a scientific review board to help bring the company's LIGHT proton therapy technology to market on schedule. The broker believes that this adds further credibility to the firm's research and is also sticking to its 9p target price. The shares fell by 0.03p to 3.9p."

k9maggie 03 Dec 2014

Re: Today's drop ???? is it just adjusting following Daily Mail MIDUS hype....k9

caloona 21 Nov 2014

Today's drop Anyone got any clues?

23Jez 19 Nov 2014

Re: competition Yes, I did. It was an excellent meeting. The board gave impressive presentations. This will be published on the corporate website.What ever eventually happens to this company, in my opinion, they are at the forefront of game changing technology. The meeting was well attended. I had the opportunity to talk to very interesting people including board members after the formal part of the meeting. All in all I had a most interesting day at one of my favourite London venues. I will post further when I have had more time to think. Even though the panel spoke lucidly and were able to explain complex science in a simple way it was a lot to take in even for someone like myself who is medically qualified and worked in related fields for over 30 years..Several private investors emphasised both formally and informally that PIs wish to be eligible to participate in any further cash raising initiatives. I asked the question about competitors and essentially it seems that although other groups are working on novel ways to accelerate photons, no one else has advanced as far as AVO in getting a a product so close to clinical testing. This is much as I said in a previous post on this issue. I will do some more research and post my comments in about a weeks time. It will give everyone time to read the presentation document.As always DYOR 23Jez

Cwmgwrach 18 Nov 2014

Re: competition Did anyone make it to today's presentation. I was unable to go but would have liked to get an answer to my previous question.

Page